Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a05:640c:1195:b0:1eb:e128:bbe3 with SMTP id o21csp114165eip;
        Wed, 17 Jan 2024 15:09:13 -0800 (PST)
X-Google-Smtp-Source: AGHT+IExIM5LFD7Ewy+g9PSFRxdx7AP1Iqlps6mMeQm69ney6feT5xlV5KM4j0BZSxItrWa6SVW2
X-Received: by 2002:a05:620a:26aa:b0:781:2c00:c89d with SMTP id c42-20020a05620a26aa00b007812c00c89dmr12542458qkp.42.1705532953388;
        Wed, 17 Jan 2024 15:09:13 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705532953; cv=none;
        d=google.com; s=arc-20160816;
        b=zZhIk+kvASZUJxx82eBTnG18vA2xtYAogXGAZ6+KugboFW7gN29Z+k+HclDOUO3g5k
         2qFQ9EhPAgieW+QTm98oewznPRpWdCnaes7A30E5rko8YbxitIbjYl4P/MTCb//tCFhK
         Nk7xxHj5vHKXAnTT3Uu9xGuxqS+Q9xEA+TZ0jom/XvfqF5dDOXiXf13ijIpcCvP1j+wN
         aANDQ0ncEfmHuRyKx2NLxVuCZDslvSsvIryc3IErVPthQTtGt3DWtUf8bVeiM8X5H7HB
         AcuTOv/DUUwcPkYYy2CQHqlRaFuh67ljyaTR5F0nQ3t03pjz/xXQ6DmQ3f20TXV6tdpK
         n0qA==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=lv1zK9xkOq+CGNR9oxOXYuJfFhQsFCqsWJCjg9Z9nr0=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=PENpvFH0kkbc5BVhJg5joRood6zh2c7G6temhArvZJK8c0VbELyoI7P81NC6jGMbEr
         fbDJM3yXYZbpdzE/O49f/JhDoeYKCPcqL7AgeB0QIDI02vHqybOmbH5BAElskPxGJBCt
         kwicqypWbPgaIM2XdToP9LLSANTsyX8TFDB5HSypQ65RwG1O8oOeQeNktlz9PIkMRNcu
         g/QAZDEn0ga2DI51qBIkV1JWbG8ua8+C9VugWN+DSNTNeQFgQfeOvd8vsOMkcJOMcah2
         th2KPO4MSsxCgAo/SF6KfxrnamCbMidF6cUryc2oP3jW52UkAeCVjFcgv73uuo9uBknq
         fWQA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=n8WMkeOY;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b="WBAB72p/";
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id p10-20020a05620a056a00b007833b44dd66si12382752qkp.345.2024.01.17.15.09.13
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Wed, 17 Jan 2024 15:09:13 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=n8WMkeOY;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b="WBAB72p/";
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=lv1zK9xkOq+CGNR9oxOXYuJfFhQsFCqsWJCjg9Z9nr0=;
	b=n8WMkeOYJ7pwLsGZH5yGYf55dcpuIb+/xQt0GN9Ue/ks4cezJG7P/5mvDq4GZ+pkYyKL
	iamRy8evNRuPb8l7yb5Nz2OoDJu0wTUQ6cUSogUh6IciLHByJTnTMBU86IOMWOzohsN4H7
	0g/tjzgPI2P2FGsPw7JU9Dzw1zRbqEjBgmQmGf19oV1KtIsHQHf3S+/7lbojcl8s6MKy/b
	bSmo983v4QbJbaKdeKzRWGo+ypvHY3QvTRJwdkvHO5CU2vdbg3GuDugUQE8XBB+v8lx9Mf
	nVvLKTxldJ+Mc3zfbZ1kIbyZ9JPXlW7fDJCU/Hi7+9X5SLtZ9+/5KfTV3RajBtBA==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=lv1zK9xkOq+CGNR9oxOXYuJfFhQsFCqsWJCjg9Z9nr0=;
	b=WBAB72p/3u3BiL/lhUC/dVm/aixty31xp5gWc6Bv1sKk7tep4Y/EgmWm4b7rOZbv4od9
	o2vR1YRfruMKkWX98pT9wdoca4vPRNiYYYkvJB3fk3C2ENoRlKM1Lb3cSuRH5XnYs8Hw0Y
	zLZHxDE32NMsJpHcMYI28NwF8cVJrHK0Q=
Received: by filterdrecv-b7c5b88-kr28j with SMTP id filterdrecv-b7c5b88-kr28j-1-65A85E17-3F
        2024-01-17 23:09:11.730120724 +0000 UTC m=+7964835.475160350
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-28 (SG) with HTTP
	id YcAfhBAlSoOtbInzpzgqvQ
	Wed, 17 Jan 2024 23:09:11.720 +0000 (UTC)
Content-Type: multipart/alternative; boundary=d94986bd4c953e1405b1961628e72b6783222af0da2d9d78c4cfc4d3c66e
Date: Wed, 17 Jan 2024 23:09:13 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <YcAfhBAlSoOtbInzpzgqvQ@geopod-ismtpd-28>
Subject: PRO/AH/EDR> Malaria - Cape Verde: elimination, WHO
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBkbpGTKV+zRaKKGCT7LulpjAmtiowYFi1wfcFA?=
 =?us-ascii?Q?KqKeu4hUGQoesPDbLRELN9v09vPh9l2L57mM4A3?=
 =?us-ascii?Q?cJQcIjfL9++8OYrTSjf5HHdiL4X5w13ryraIgpr?=
 =?us-ascii?Q?+kxdNcmQJNPM7e79bnLrmaXV7KrTWcg5OW1cizD?=
 =?us-ascii?Q?71lDkWOQ4=2FYTIFfFAd63LB4WlUmK6NHHgL4F=2Fw?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUiShGf=2FO8XJWpH34Od4Nd?=
 =?us-ascii?Q?fxXa6jil96uRcJkF+N+LeVnO1tx80ddOyoyOo=2Fc?=
 =?us-ascii?Q?Brxcl3ERAm0cOY743=2FFH59DWiSf5OzXORh1DLKt?=
 =?us-ascii?Q?hb1NMKty3PsA5ju0ZzxCrq1WQuZSEQf=2FJlWtgqv?=
 =?us-ascii?Q?cZmsyCHlNUZsD7M8SVDfm5V9nVxMiqzLj9KL7mT?=
 =?us-ascii?Q?8u2XqKpv23DnzbduVRHzKYolWW4XpnwLKWa6YGp?=
 =?us-ascii?Q?WlMpjtYeEwkGUVmXC=2Fg6U5j8vzsAufG4vEqFKqu?=
 =?us-ascii?Q?ESeymsLdAIrB4mfScZ4uJX0hwqZvXwcq+zmEmQD?=
 =?us-ascii?Q?MWZer9Dt2nkmbq3tWx0585qU4k6lUlcAk0d8QJt?=
 =?us-ascii?Q?PwnNRLcnJYfHtKvVa7uAO3gqMvcwGTcWc6DcUa5?=
 =?us-ascii?Q?J4RNwqRobKplep8flXBMRzf0zIV3jvT2PbiNCD1?=
 =?us-ascii?Q?ovEc+2N2CMo44xLTxPuU4AIo2n3x1G=2FlkioX+d5?=
 =?us-ascii?Q?1sWIPw=2FLUjSC4T8TYb4RZMxAYm7dzOBRuSMMS5w?=
 =?us-ascii?Q?48vk54s66EnrBnetCTszAJIBtnX9wgMC0+Ahso0?=
 =?us-ascii?Q?EjCebT3cOgtt=2F+28AfM3sGkRLJnX8fEFc=2FW6Jmq?=
 =?us-ascii?Q?Ks6p+XvhK9JcUbWcL=2FXpu5WlWta0M2A1CUCexH3?=
 =?us-ascii?Q?MLgzvKdkPrXuCgi4A4IEOx+M7P3bOJ9NDrg6AxG?=
 =?us-ascii?Q?IgKXCCXt2fPuFNPSJz=2FDJt9I9iuaYax9XowO26C?=
 =?us-ascii?Q?8ZblcwpzgbzIDugwCJ2c0JkRYE606X25BRC4uSc?=
 =?us-ascii?Q?+LybYEZg3dtADYG+Jf9TkQ10Lw=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2E16e1ipuET?=
 =?us-ascii?Q?-VaiXa8ZxVgp7wxMjwGjJsuJ3ZjM3=5FK7dtoMDAw?=
 =?us-ascii?Q?dTAwMJejehhv2tdFaw79CFi6JFVL30NG3OiTPIA?=
 =?us-ascii?Q?mc9K5iaf1wjN=5Fe95oLFDK6q0tjIeMtefStijvn0?=
 =?us-ascii?Q?wirBaP7iMezjZq35L506RnVM9d7i-ivrubOOO2a?=
 =?us-ascii?Q?-0EDEABn-8WY9LuVg=3D=3D=2Eb-ww1M8XU2DeclmHPZa?=
 =?us-ascii?Q?gxmHYFojLo4DFGjGmZNlxsiRoMDAwdTAwMPurPc?=
 =?us-ascii?Q?QsqfCohOzD2t8bebuwvAA5O89ohORlw30TupcNy?=
 =?us-ascii?Q?NNUSsLlQf7gLfh2=5FyXXZLIk2drf3UPhPeswn0g3?=
 =?us-ascii?Q?vC1oEGfItDUCvlzd8XLJzXIOL=5FJ6glKLCjNM-NK?=
 =?us-ascii?Q?mbKs3yY5LhBv9NyxszI2EXPGSrJ60M49B3PS031?=
 =?us-ascii?Q?iXvvsBCGF0IpnFr8Euj7uoehm-VKoDA5w-4ckPZ?=
 =?us-ascii?Q?kGFC6SsU3qoCyG5jHgF5cWu380cpcGeBuAdqWXJ?=
 =?us-ascii?Q?yJ9MLDHjpx1s6PETuk9DwTRFVhRwyUQo3XO-1ki?=
 =?us-ascii?Q?IcRj7yZJffT2kTySutWL96GW=5FWVCP-v=5F-C775J7?=
 =?us-ascii?Q?PYQ14NNMcHPBITrOEk8gGPue=5FpVw4pqcbK9uWtx?=
 =?us-ascii?Q?NTSgmbN-9PBL-AHJBWvwXD-Lhtnem7QhAOMjNZK?=
 =?us-ascii?Q?l11O2jPilOoBMVuraGldf983GQz99XRWUcYrcnb?=
 =?us-ascii?Q?BWLyUtEb-832F7lgPDIsl9BSE58e1=5FvhPBHp2vb?=
 =?us-ascii?Q?z2afj7KblnEqVHc-43JIKmRjIAAKFBNQgOfJCQE?=
 =?us-ascii?Q?HlDWWmZkCnhDOmYJkPqOpotiw6iadi77ZjqC-Mk?=
 =?us-ascii?Q?-nFDLaDMCOea-qkE5VYtCjJS4gVHlZE-lRPog6T?=
 =?us-ascii?Q?=5FY4=5FCvbdy-eHkswl4qtGgoCzCoYnYiVTbTj84X9?=
 =?us-ascii?Q?v24laoPe--X2MK-J787=5FGPbKtNgFw75hrXzstN2?=
 =?us-ascii?Q?VTS32EnL9HUYW-HVs-puqgI=5FVUn62fWiCzA5xnp?=
 =?us-ascii?Q?A-QlzyeytNRTnElcmo6-r7XL=5F=5FO-OAj1zqat5pU?=
 =?us-ascii?Q?Jrs8wSIkK3lE9twN7J4YowiuwJ1pxfCIDmKjS7M?=
 =?us-ascii?Q?DUwyOy6iINnrUxlIahyvaGFW-GAGy6E5jIMHMzn?=
 =?us-ascii?Q?=5FWhmEiv7nRw7FOW5gc=5FZufuND3jCaCcnMt3GQWq?=
 =?us-ascii?Q?CQ9a9Ymiiq6fCs9ol44ngK9oHHEHu=5F38TGJhRzP?=
 =?us-ascii?Q?JKQMqHrLwVvoU066-5HOc-PnDUEDtdMQ54xXouw?=
 =?us-ascii?Q?gHyFdS3KsHqBjs-Bp7sekTPln1z304rz823HhtX?=
 =?us-ascii?Q?qb7V5mejsfQ7vohu5YBKA7525aMmhQoBZ0B4pBs?=
 =?us-ascii?Q?3zdKhA=3D=3D=3E?=

--d94986bd4c953e1405b1961628e72b6783222af0da2d9d78c4cfc4d3c66e
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=us-ascii
Mime-Version: 1.0

MALARIA - CAPE VERDE: ELIMINATION, WHO
**************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Fri 12 Jan 2024
Source: WHO [edited]
<https://www.who.int/news/item/12-01-2024-who-certifies-cabo-verde-as-malar=
ia-free--marking-a-historic-milestone-in-the-fight-against-malaria>


The World Health Organization (WHO) has certified Cabo Verde as a
malaria-free country, marking a significant achievement in global
health. With this announcement, Cabo Verde joins the ranks of 43
countries and one territory that WHO has awarded this certification
to.

Cabo Verde is the 3rd country to be certified in the WHO African
region, joining Mauritius and Algeria, which were certified in 1973
and 2019, respectively. Malaria burden is the highest on the African
continent, which accounted for approximately 95% of global malaria
cases and 96% of related deaths in 2021.

Certification of malaria elimination will drive positive development
on many fronts for Cabo Verde. Systems and structures built for
malaria elimination have strengthened the health system and will be
used to fight other mosquito-borne diseases such as dengue fever.
Travelers from non-malaria endemic regions can now travel to the
islands of Cabo Verde without fear of local malaria infections and the
potential inconvenience of preventive treatment measures. This has the
potential to attract more visitors and boost socio-economic activities
in a country where tourism accounts for approximately 25% of GDP.

"I salute the government and people of Cabo Verde for their unwavering
commitment and resilience in their journey to eliminating malaria,"
said WHO Director-General Dr Tedros Adhanom Ghebreyesus. "WHO's
certification of Cabo Verde being malaria-free is testament to the
power of strategic public health planning, collaboration, and
sustained effort to protect and promote health. Cabo Verde's success
is the latest in the global fight against malaria, and gives us hope
that with existing tools, as well as new ones, including vaccines, we
can dare to dream of a malaria-free world."

Certification of malaria elimination is the official recognition by
WHO of a country's malaria-free status. The certification is granted
when a country has shown -- with rigorous, credible evidence -- that
the chain of indigenous malaria transmission by _Anopheles_ mosquitoes
has been interrupted nationwide for at least the past 3 consecutive
years. A country must also demonstrate the capacity to prevent the
re-establishment of transmission.

"The certification as a malaria-free country has a huge impact, and
it's taken a long time to get to this point. In terms of the country's
external image, this is very good, both for tourism and for everyone
else. The challenge that Cabo Verde has overcome in the health system
is being recognised", said Cabo Verde Prime Minister Ulisses Correia e
Silva.

Cabo Verde, an archipelago of 10 islands in the Central Atlantic
Ocean, has faced significant malaria challenges. Before the 1950s, all
islands were affected by malaria. Severe epidemics were regular
occurrences in the most densely populated areas until targeted
interventions were implemented. Through the targeted use of
insecticide spraying, the country eliminated malaria twice: in 1967
and 1983. However, subsequent lapses in vector control led to a return
of the disease. Since the last peak of malaria cases in the late
1980s, malaria in Cabo Verde has been confined to 2 islands: Santiago
and Boa Vista, which have now both been malaria-free since 2017.

"Cabo Verde's achievement is a beacon of hope for the African Region
and beyond. It demonstrates that with strong political will, effective
policies, community engagement, and multisectoral collaboration,
malaria elimination is an achievable goal," said Dr Matshidiso Moeti,
WHO Regional Director for Africa. "The attainment of this milestone by
Cabo Verde is an inspiring example for other nations to follow."

Cabo Verde's journey to malaria elimination has been long and received
a boost with the inclusion of this objective in its national health
policy in 2007. A strategic malaria plan from 2009 to 2013 laid the
groundwork for success, focusing on expanded diagnosis, early and
effective treatment, and the reporting and investigating all cases. To
stem the tide of imported cases from mainland Africa, diagnosis and
treatment were provided free of charge to international travelers and
migrants.

In 2017, the country turned an outbreak into an opportunity. Cabo
Verde identified problems and made improvements, leading to zero
indigenous cases for 3 consecutive years.

During the ongoing COVID-19 pandemic, the country safeguarded
progress. Efforts focused on improving the quality and sustainability
of vector control and malaria diagnosis, and strengthening malaria
surveillance, especially at ports and airports, in the capital city,
and in areas with a risk of malaria re-establishment.

Collaboration between the Ministry of Health and various government
departments focused on the environment, agriculture, transportation,
tourism, and more played a pivotal role in Cabo Verde's success. The
inter-ministerial commission for vector control, chaired by the prime
minister, was key to elimination. The collaborative effort and the
commitment of community-based organizations and NGOs demonstrate the
importance of a holistic approach to public health.

As Cabo Verde celebrates this monumental achievement, the global
community commends its leaders, healthcare professionals, and citizens
for their dedication to eliminating malaria and creating a healthier
future for all.

--
Communicated by:
ProMED
via
ProMED-EAFR

[This marks a significant accomplishment in addressing the malaria
epidemic in this west African nation. Undoubtedly, malaria continues
to be the foremost contributor to illness in this region of the
continent and a primary driver of poverty. This achievement will not
only stimulate economic activities in the country but also enhance the
quality of life for the population. - Mod.RBY

ProMED map of Cape Verde:
<https://promedmail.org/promed-post?place=3D8714240,15>]

[See Also:
Malaria - Tanzania: (Zanzibar) re-emergence
http://promedmail.org/post/20240113.8714213
2023
----
Malaria - Africa (07): Ethiopia (OR) continued increase, RFI
http://promedmail.org/post/20231001.8712408
Malaria - Africa (06): Ethiopia, increase, RFI
http://promedmail.org/post/20230706.8710994
Malaria - Africa (05): Kenya (MB) fatal, not linked to Anopheles
stephensi http://promedmail.org/post/20230524.8710210
Malaria - Africa (04): Kenya (BN), Congo DR (KS), Nigeria (AN), Ghana
http://promedmail.org/post/20230502.8709805
Malaria - Africa (03): Ghana, Nigeria, new R21/Matrix-M vaccine
approved http://promedmail.org/post/20230421.8709605
Malaria - Africa (02): Sudan, Uganda, increase
http://promedmail.org/post/20230414.8709477
Malaria - Africa: Kenya (MB) Anopheles stephensi, 1st rep, alert
http://promedmail.org/post/20230222.8708528
Malaria, falciparum - UK: artemisinin resistance, ex Uganda
http://promedmail.org/post/20230217.8708458
2022
----
Malaria - Africa (05): Ethiopia, Anopheles stephensi
http://promedmail.org/post/20221102.8706520
Malaria - Kenya: (KK) http://promedmail.org/post/20220528.8703500
Malaria - Africa (04): Burundi, increase
http://promedmail.org/post/20220503.8702997
World Malaria Day: Africa http://promedmail.org/post/20220501.8702959
Malaria - Africa (03): vaccine update
http://promedmail.org/post/20220423.8702794
Malaria - Africa (02): Mozambique (NS) increase
http://promedmail.org/post/20220410.8702527
Malaria - Africa: South Africa (WC)
http://promedmail.org/post/20220305.8701819
2021
----
Malaria: World Malaria Report 2021
http://promedmail.org/post/20211219.8700380
Malaria - Africa: RTS,S/AS01 child vaccine, WHO
http://promedmail.org/post/20211007.8698896
Malaria - Uganda: artemisinin resistance
http://promedmail.org/post/20210924.8698670
Malaria - Burkina Faso: genetically modified mosquito
http://promedmail.org/post/20210601.8414384
Malaria vaccine trial, high efficacy
http://promedmail.org/post/20210424.8326270
Malaria, artemisinin resistance - Africa
http://promedmail.org/post/20210417.8313098
Invasive mosquito, A. stephensi - Africa: malaria
http://promedmail.org/post/20210202.8156660
2020
----
Malaria - Namibia (02): (ZA) resurgence
http://promedmail.org/post/20201204.7992054
World Malaria Report 2020: Asia
http://promedmail.org/post/20201130.7982459
Invasive mosquito - Africa
http://promedmail.org/post/20200824.7708503
and other items in the archives]
.................................................rby/tw/ya/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DfjSpAIy6fNPYTZQpBDNDAb6z7fStXc1u-hJU6KLBr_doMDAwdTAwMM0qwdL=
BuHgbBEX1HSwK_uGEQ5jxlG_SznSSz9xGCdfdQK_ynUMG711HFW0t6p5rCe9UToxxyqEusUhf96=
2T7pc_BReGFakrm3WtBE2z7vJrBCuV8KT61JORGO_thPTocPizSPfdunBsPSqYaQRvqRZ_T0c0c=
p3iUHn3ad7DIySEkA45GZpKwl1uiCFt4kWEoZ-5s1XJKemasn1bAamMRp0VJXwhKeTW8gvfWypN=
h2eao-PxuruFpnprlaqnY262cB03uqaGP4ceZiQ2x_VLqfNnN5Y49LTJ1AGJAZaS1ggIpqPjPnY=
TLw68g-MLPoqd2GKDPHuE3CELD7Ma40YyAwZlepyyarwnqFL19gcpP4iiWgLG9E3PZlCi77s0IJ=
xsQz-yvfoonFsBRQue8ABw0o4zDv_ttjbdoIX7-vbRm9RqqHd9IMRaAXAolALcVVJHdOEtkxgBg=
0dR8kPps8dl22_PBu_w1FUvWRTo5GCMCIyLj_xI8QqtJ_rrAeT_PC0VOPnqUFtXXu6RGi1eGKaN=
WkNT6JGbK1bThU9NvhuMdUq3xg8HHa24-OL-kiSi4FyCK4VxmZ_ehAwLwetpogUg0DyRagVH05X=
Q-nRp4-vwpAkFhX2IJIH9kyfs7y6XsPfHYbng1GuUr2f-xJkPkNA5t42Q7HB7ZmyPnCtQpmSS6i=
r4qI8aaBSIoqyIqayZGdftlOb7j1KngoBqRWY1A8vxcyRQC9p1M8n6oNzx5l7Xe5GxSolNaXoRQ=
ORsMSte2u-4T1cbjYJvPInvk84DUOUT4Zvubx9wTCDTO5j3vqpLs3F1SKmBsnTAYyqspBtkA09E=
7WJqb8L1bjld78JMqgcn5tAKbyQEy9xSRdBuMrrNfQGL9Joe9VseSHrUsHydDbuV0RF9d98sqZe=
8TzgOktAsvNaBU3s_uvVhqc_3vxGv6aMKB5DXqMccbr48AW-pWBKPHm9UMXJ-qM_4ZzRuFWFsYz=
4F-JeiBtBfG28DtLmr_AxkfafNhK7DP0jZzsfCHaXCaUl0eAAX9Ge4fLzucDl60DN4K3DdB-0PA=
GVJBfEAmETrgKFVI49JYkqDhDOlKiG7-okDxu1jTrQk0NA9pArGbB2_CDAUVDNrtdXK_my9xYjy=
E8UPvvYs-Jpv24zm9qnrLTcyzI7QyEL06tNYwv1LzJNIpD7Bq_oauyRL-HW58-lD )
############################################################
############################################################

--d94986bd4c953e1405b1961628e72b6783222af0da2d9d78c4cfc4d3c66e
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=us-ascii
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MALARIA - CAPE VERDE: ELIMINATION, WHO<br>***************************=
***********<br>A ProMED-mail post<br><a href=3D"https://u19268662.ct.sendgr=
id.net/ss/c/wscE2ng5fl6JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3H=
A/432/ggdN5p6xTF6c1YpjTBS3uA/h0/EIAnSWh1V_3vKa5LxXDo2Qg9ZDJ8cxLbPpOZHrmrs_c=
">http://www.promedmail.org</a><br>ProMED-mail is a program of the<br>Inter=
national Society for Infectious Diseases<br><a href=3D"https://u19268662.ct=
.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/432/ggdN5p6x=
TF6c1YpjTBS3uA/h1/HTC1Snhz7AHQBNnkJXP_vi0zdNkSc8HeNRrDa2jOhto">http://www.i=
sid.org</a><br><br>Date: Fri 12 Jan 2024=0D<br>Source: WHO [edited]=0D<br><=
a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_csrC34X_iXpbYoMamxCzlv=
gMKE9BBL3U26Z4UMGXAmAMDEsVF8Du92OBR8-NMsLYrR48pz7ncjAj3uRQmrzFYd_S9yLTZg5yE=
AiFLkPhW4wRpKpjcrifPoDqjjb0ocZokjdOJmTyj0roePvPu826hhdllfn9ZlKWn00UX2h-I8MW=
z0jshTAjrCVUFfNZRU-y-454TMsdmwnLBOn_qw/432/ggdN5p6xTF6c1YpjTBS3uA/h2/dCttfH=
ltM5eq-lZqmUaUpgX48j6O3xZyPjqCwyNWA0Q">https://www.who.int/news/item/12-01-=
2024-who-certifies-cabo-verde-as-malaria-free--marking-a-historic-milestone=
-in-the-fight-against-malaria</a>=0D<br>=0D<br>=0D<br>The World Health Orga=
nization (WHO) has certified Cabo Verde as a<br>malaria-free country, marki=
ng a significant achievement in global<br>health. With this announcement, C=
abo Verde joins the ranks of 43<br>countries and one territory that WHO has=
 awarded this certification<br>to.=0D<br>=0D<br>Cabo Verde is the 3rd count=
ry to be certified in the WHO African<br>region, joining Mauritius and Alge=
ria, which were certified in 1973<br>and 2019, respectively. Malaria burden=
 is the highest on the African<br>continent, which accounted for approximat=
ely 95% of global malaria<br>cases and 96% of related deaths in 2021.=0D<br=
>=0D<br>Certification of malaria elimination will drive positive developmen=
t<br>on many fronts for Cabo Verde. Systems and structures built for<br>mal=
aria elimination have strengthened the health system and will be<br>used to=
 fight other mosquito-borne diseases such as dengue fever.<br>Travelers fro=
m non-malaria endemic regions can now travel to the<br>islands of Cabo Verd=
e without fear of local malaria infections and the<br>potential inconvenien=
ce of preventive treatment measures. This has the<br>potential to attract m=
ore visitors and boost socio-economic activities<br>in a country where tour=
ism accounts for approximately 25% of GDP.=0D<br>=0D<br>"I salute the gover=
nment and people of Cabo Verde for their unwavering<br>commitment and resil=
ience in their journey to eliminating malaria,"<br>said WHO Director-Genera=
l Dr Tedros Adhanom Ghebreyesus. "WHO's<br>certification of Cabo Verde bein=
g malaria-free is testament to the<br>power of strategic public health plan=
ning, collaboration, and<br>sustained effort to protect and promote health.=
 Cabo Verde's success<br>is the latest in the global fight against malaria,=
 and gives us hope<br>that with existing tools, as well as new ones, includ=
ing vaccines, we<br>can dare to dream of a malaria-free world."=0D<br>=0D<b=
r>Certification of malaria elimination is the official recognition by<br>WH=
O of a country's malaria-free status. The certification is granted<br>when =
a country has shown -- with rigorous, credible evidence -- that<br>the chai=
n of indigenous malaria transmission by _Anopheles_ mosquitoes<br>has been =
interrupted nationwide for at least the past 3 consecutive<br>years. A coun=
try must also demonstrate the capacity to prevent the<br>re-establishment o=
f transmission.=0D<br>=0D<br>"The certification as a malaria-free country h=
as a huge impact, and<br>it's taken a long time to get to this point. In te=
rms of the country's<br>external image, this is very good, both for tourism=
 and for everyone<br>else. The challenge that Cabo Verde has overcome in th=
e health system<br>is being recognised", said Cabo Verde Prime Minister Uli=
sses Correia e<br>Silva.=0D<br>=0D<br>Cabo Verde, an archipelago of 10 isla=
nds in the Central Atlantic<br>Ocean, has faced significant malaria challen=
ges. Before the 1950s, all<br>islands were affected by malaria. Severe epid=
emics were regular<br>occurrences in the most densely populated areas until=
 targeted<br>interventions were implemented. Through the targeted use of<br=
>insecticide spraying, the country eliminated malaria twice: in 1967<br>and=
 1983. However, subsequent lapses in vector control led to a return<br>of t=
he disease. Since the last peak of malaria cases in the late<br>1980s, mala=
ria in Cabo Verde has been confined to 2 islands: Santiago<br>and Boa Vista=
, which have now both been malaria-free since 2017.=0D<br>=0D<br>"Cabo Verd=
e's achievement is a beacon of hope for the African Region<br>and beyond. I=
t demonstrates that with strong political will, effective<br>policies, comm=
unity engagement, and multisectoral collaboration,<br>malaria elimination i=
s an achievable goal," said Dr Matshidiso Moeti,<br>WHO Regional Director f=
or Africa. "The attainment of this milestone by<br>Cabo Verde is an inspiri=
ng example for other nations to follow."=0D<br>=0D<br>Cabo Verde's journey =
to malaria elimination has been long and received<br>a boost with the inclu=
sion of this objective in its national health<br>policy in 2007. A strategi=
c malaria plan from 2009 to 2013 laid the<br>groundwork for success, focusi=
ng on expanded diagnosis, early and<br>effective treatment, and the reporti=
ng and investigating all cases. To<br>stem the tide of imported cases from =
mainland Africa, diagnosis and<br>treatment were provided free of charge to=
 international travelers and<br>migrants.=0D<br>=0D<br>In 2017, the country=
 turned an outbreak into an opportunity. Cabo<br>Verde identified problems =
and made improvements, leading to zero<br>indigenous cases for 3 consecutiv=
e years.=0D<br>=0D<br>During the ongoing COVID-19 pandemic, the country saf=
eguarded<br>progress. Efforts focused on improving the quality and sustaina=
bility<br>of vector control and malaria diagnosis, and strengthening malari=
a<br>surveillance, especially at ports and airports, in the capital city,<b=
r>and in areas with a risk of malaria re-establishment.=0D<br>=0D<br>Collab=
oration between the Ministry of Health and various government<br>department=
s focused on the environment, agriculture, transportation,<br>tourism, and =
more played a pivotal role in Cabo Verde's success. The<br>inter-ministeria=
l commission for vector control, chaired by the prime<br>minister, was key =
to elimination. The collaborative effort and the<br>commitment of community=
-based organizations and NGOs demonstrate the<br>importance of a holistic a=
pproach to public health.=0D<br>=0D<br>As Cabo Verde celebrates this monume=
ntal achievement, the global<br>community commends its leaders, healthcare =
professionals, and citizens<br>for their dedication to eliminating malaria =
and creating a healthier<br>future for all.=0D<br>=0D<br>--=0D<br>Communica=
ted by:=0D<br>ProMED=0D<br>via=0D<br>ProMED-EAFR<br><br>[This marks a signi=
ficant accomplishment in addressing the malaria<br>epidemic in this west Af=
rican nation. Undoubtedly, malaria continues<br>to be the foremost contribu=
tor to illness in this region of the<br>continent and a primary driver of p=
overty. This achievement will not<br>only stimulate economic activities in =
the country but also enhance the<br>quality of life for the population. - M=
od.RBY=0D<br>=0D<br>ProMED map of Cape Verde:<br><a href=3D"https://u192686=
62.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqX=
YXU-aTMPJ8yTh3H_8e82MYYI7LPxn_3J0Hg/432/ggdN5p6xTF6c1YpjTBS3uA/h3/fWT08lDNL=
gCUo8THLacScd7lo8cSBa8gw0g71rgnfOQ">https://promedmail.org/promed-post?plac=
e=3D8714240,15</a>]<br><br>[See Also:<br>Malaria - Tanzania: (Zanzibar) re-=
emergence<br>http://promedmail.org/post/20240113.8714213=0D<br>2023=0D<br>-=
---=0D<br>Malaria - Africa (07): Ethiopia (OR) continued increase, RFI<br>h=
ttp://promedmail.org/post/20231001.8712408=0D<br>Malaria - Africa (06): Eth=
iopia, increase, RFI<br>http://promedmail.org/post/20230706.8710994=0D<br>M=
alaria - Africa (05): Kenya (MB) fatal, not linked to Anopheles<br>stephens=
i http://promedmail.org/post/20230524.8710210=0D<br>Malaria - Africa (04): =
Kenya (BN), Congo DR (KS), Nigeria (AN), Ghana<br>http://promedmail.org/pos=
t/20230502.8709805=0D<br>Malaria - Africa (03): Ghana, Nigeria, new R21/Mat=
rix-M vaccine<br>approved http://promedmail.org/post/20230421.8709605=0D<br=
>Malaria - Africa (02): Sudan, Uganda, increase<br>http://promedmail.org/po=
st/20230414.8709477=0D<br>Malaria - Africa: Kenya (MB) Anopheles stephensi,=
 1st rep, alert<br>http://promedmail.org/post/20230222.8708528=0D<br>Malari=
a, falciparum - UK: artemisinin resistance, ex Uganda<br>http://promedmail.=
org/post/20230217.8708458=0D<br>2022=0D<br>----=0D<br>Malaria - Africa (05)=
: Ethiopia, Anopheles stephensi<br>http://promedmail.org/post/20221102.8706=
520=0D<br>Malaria - Kenya: (KK) http://promedmail.org/post/20220528.8703500=0D=
<br>Malaria - Africa (04): Burundi, increase<br>http://promedmail.org/post/=
20220503.8702997=0D<br>World Malaria Day: Africa http://promedmail.org/post=
/20220501.8702959=0D<br>Malaria - Africa (03): vaccine update<br>http://pro=
medmail.org/post/20220423.8702794=0D<br>Malaria - Africa (02): Mozambique (=
NS) increase<br>http://promedmail.org/post/20220410.8702527=0D<br>Malaria -=
 Africa: South Africa (WC)<br>http://promedmail.org/post/20220305.8701819=0D=
<br>2021=0D<br>----=0D<br>Malaria: World Malaria Report 2021<br>http://prom=
edmail.org/post/20211219.8700380=0D<br>Malaria - Africa: RTS,S/AS01 child v=
accine, WHO<br>http://promedmail.org/post/20211007.8698896=0D<br>Malaria - =
Uganda: artemisinin resistance<br>http://promedmail.org/post/20210924.86986=
70=0D<br>Malaria - Burkina Faso: genetically modified mosquito<br>http://pr=
omedmail.org/post/20210601.8414384=0D<br>Malaria vaccine trial, high effica=
cy<br>http://promedmail.org/post/20210424.8326270=0D<br>Malaria, artemisini=
n resistance - Africa<br>http://promedmail.org/post/20210417.8313098=0D<br>=
Invasive mosquito, A. stephensi - Africa: malaria<br>http://promedmail.org/=
post/20210202.8156660=0D<br>2020=0D<br>----=0D<br>Malaria - Namibia (02): (=
ZA) resurgence<br>http://promedmail.org/post/20201204.7992054=0D<br>World M=
alaria Report 2020: Asia<br>http://promedmail.org/post/20201130.7982459=0D<=
br>Invasive mosquito - Africa<br>http://promedmail.org/post/20200824.770850=
3=0D<br>and other items in the archives]<br>...............................=
..................rby/tw/ya/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DfjSpAIy6fNPYTZQpBDNDAb6z7fStXc1u-hJU6KLBr_doMDAwdT=
AwMM0qwdLBuHgbBEX1HSwK_uGEQ5jxlG_SznSSz9xGCdfdQK_ynUMG711HFW0t6p5rCe9UToxxy=
qEusUhf962T7pc_BReGFakrm3WtBE2z7vJrBCuV8KT61JORGO_thPTocPizSPfdunBsPSqYaQRv=
qRZ_T0c0cp3iUHn3ad7DIySEkA45GZpKwl1uiCFt4kWEoZ-5s1XJKemasn1bAamMRp0VJXwhKeT=
W8gvfWypNh2eao-PxuruFpnprlaqnY262cB03uqaGP4ceZiQ2x_VLqfNnN5Y49LTJ1AGJAZaS1g=
gIpqPjPnYTLw68g-MLPoqd2GKDPHuE3CELD7Ma40YyAwZlepyyarwnqFL19gcpP4iiWgLG9E3PZ=
lCi77s0IJxsQz-yvfoonFsBRQue8ABw0o4zDv_ttjbdoIX7-vbRm9RqqHd9IMRaAXAolALcVVJH=
dOEtkxgBg0dR8kPps8dl22_PBu_w1FUvWRTo5GCMCIyLj_xI8QqtJ_rrAeT_PC0VOPnqUFtXXu6=
RGi1eGKaNWkNT6JGbK1bThU9NvhuMdUq3xg8HHa24-OL-kiSi4FyCK4VxmZ_ehAwLwetpogUg0D=
yRagVH05XQ-nRp4-vwpAkFhX2IJIH9kyfs7y6XsPfHYbng1GuUr2f-xJkPkNA5t42Q7HB7ZmyPn=
CtQpmSS6ir4qI8aaBSIoqyIqayZGdftlOb7j1KngoBqRWY1A8vxcyRQC9p1M8n6oNzx5l7Xe5Gx=
SolNaXoRQORsMSte2u-4T1cbjYJvPInvk84DUOUT4Zvubx9wTCDTO5j3vqpLs3F1SKmBsnTAYyq=
spBtkA09E7WJqb8L1bjld78JMqgcn5tAKbyQEy9xSRdBuMrrNfQGL9Joe9VseSHrUsHydDbuV0R=
F9d98sqZe8TzgOktAsvNaBU3s_uvVhqc_3vxGv6aMKB5DXqMccbr48AW-pWBKPHm9UMXJ-qM_4Z=
zRuFWFsYz4F-JeiBtBfG28DtLmr_AxkfafNhK7DP0jZzsfCHaXCaUl0eAAX9Ge4fLzucDl60DN4=
K3DdB-0PAGVJBfEAmETrgKFVI49JYkqDhDOlKiG7-okDxu1jTrQk0NA9pArGbB2_CDAUVDNrtdX=
K_my9xYjyE8UPvvYs-Jpv24zm9qnrLTcyzI7QyEL06tNYwv1LzJNIpD7Bq_oauyRL-HW58-lD" =
target=3D"_blank" class=3D"Unsubscribe--unsubscribePreferences" style=3D"fo=
nt-family:sans-serif;text-decoration:none;">Unsubscribe Preferences</a></di=
v><br>############################################################<br>#####=
#######################################################<br><br><img src=3D"=
https://u19268662.ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/432/ggdN5p6xT=
F6c1YpjTBS3uA/ho.gif" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=
=3D"height:1px !important;width:1px !important;border-width:0 !important;ma=
rgin-top:0 !important;margin-bottom:0 !important;margin-right:0 !important;=
margin-left:0 !important;padding-top:0 !important;padding-bottom:0 !importa=
nt;padding-right:0 !important;padding-left:0 !important;"/></body>
</html>
--d94986bd4c953e1405b1961628e72b6783222af0da2d9d78c4cfc4d3c66e--
